Bridge program offers continued seizure drug access
NCT ID NCT02307578
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This program allows people who completed certain earlier studies of perampanel to keep receiving the drug until it becomes commercially available in their country. It is for those with primary generalized tonic-clonic seizures, partial onset seizures, or Lennox-Gastaut syndrome. The goal is to ensure uninterrupted treatment for those who benefit from it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LENNOX GASTAUT SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Artroscan
Ostrava-Trebovice, Czechia
-
Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktató Kórház
Miskolc, Hungary
-
Centre Neurologique William Lennox
Ottignies, Belgium
-
Childrens University Hospital
Riga, Latvia
-
Clinical Centre of Serbia
Belgrade, Serbia
-
Cliniques Universitaires Saint-Luc
Brussels, Belgium
-
Dél-Pesti Centrumkórház Országos Hematológiai és Infektológiai Intézet
Budapest, Hungary
-
Hospital Clinico San Carlos
Madrid, Spain
-
Hospital Padre Hurtado
Santiago, Chile
-
Hospital Sant Joan de Deu
Esplugues de Llobregat, Spain
-
Hospital Universitario Virgen del Rocio -
Seville, Spain
-
Hôpital Universitaire des Enfants Reine Fabiola
Brussels, Belgium
-
Instytut Psychiatrii Neurologii
Warsaw, Poland
-
Klaipeda University Hospital
Klaipėda, Lithuania
-
Magyarorszagi Reformatus Egyhaz (MRE) Bethesda Gyermekkorhaza
Budapest, Hungary
-
NZOZ Centrum Neurologii Dzieciecej i Leczenia Padaczki
Kielce, Poland
-
Nzoz Novo-Med
Katowice, Poland
-
Országos Idegsebészeti Tudományos Intézet
Budapest, Hungary
-
Oy Neurodiagnostika Ap
Tallinn, Estonia
-
Pécsi Tudományegyetem
Pécs, Hungary
-
Rajna és Fiai Kereskedelmi és Szolgáltató Kft.
Budapest, Hungary
-
Riga 1st Hospital
Riga, Latvia
-
Servus Salvus Egeszsegugyi Szolgaltato Kft.
Budapest, Hungary
-
Szpital Kliniczny im. H.Swiecickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu
Poznan, Poland
-
Tartu University Hospital
Tartu, Estonia
-
Uniwersyteckie Centrum Kliniczne - PPDS
Gdansk, Poland
-
Všeobecná fakultní nemocnice, Pragtis s.r.o
Prague, Czechia
Conditions
Explore the condition pages connected to this study.